Activest Wealth Management’s Neuropace NPCE Stock Holding History

Activest Wealth Management’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125	Closed	-$1.64K	–	1451
2026 Q1	$1.64K	Buy	+125	New	+$1.88K	﹤0.01%	980

Other funds holding NPCE

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HFS

Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Activest Wealth Management's NPCE Position: Q2 2026 in Review

Activest Wealth Management sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 125 shares — an estimated $1.64K sold.

Activest Wealth Management first reported a position in NPCE in Q1 2026 and held it in 1 quarter. The position peaked at $1.64K in Q1 2026. 4 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

Activest Wealth Management reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
Activest Wealth Management sold 125 Neuropace shares in Q2 2026, an estimated $1.64K.
Activest Wealth Management first reported a position in Neuropace in Q1 2026 and held it in 1 quarter.
Activest Wealth Management's Neuropace position peaked at $1.64K in Q1 2026.
4 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.